Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

April 27, 2015April 27, 2015

Microbiome Imbalance Can Induce Crohn’s Disease-like Inflammation

News

In a new study entitled “Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defense,” researchers report to have found that bacterial imbalance in the gut ... Read more

March 17, 2015March 17, 2015

Pediatric IBD Program Helps Children Cope with Disease

IBD News, News

Inflammatory Bowel Disease (IBD) is one of the main focuses at Penn State Hershey Children’s Hospital, part of a national network that works to improve treatment for pediatric IBD patients. The program ... Read more

March 11, 2015September 28, 2016

Children with Crohn’s Disease Experience Racial Disparities in Healthcare, Study Suggests

Crohn's Disease, News

In a new review entitled “Racial Disparities in Readmission, Complications, and Procedures in Children with Crohn’s Disease” authors describe ethnicity-based decisions in hospital care of children affected by Crohn’s disease. ... Read more

March 5, 2015

Mutated T Cell Superenhancers Drive Autoimmune Diseases Like IBD

News

In a new study entitled “Super-enhancers delineate disease-associated regulatory nodes in T cells,” researchers discovered gene alterations characteristic of autoimmune diseases, such as inflammatory bowel disease or rheumatoid arthritis, are found in ... Read more

February 10, 2015February 10, 2015

Diet is the Chief Factor Behind Gut Microbiome Diversity, Study Shows

News

In a recent study entitled “Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota,” researchers are suggesting diet may be a stronger factor in modulating microbiome in the gut compared ... Read more

December 3, 2014September 28, 2016

IBD Therapy Infliximab Tested in Pediatric Patients 7 and Under

IBD News, News

A recent study entitled “Infliximab therapy in pediatric patients 7 years of age and younger” reports that infliximab therapy is less efficient in treating inflammatory bowel disease in children aged ... Read more

December 2, 2014December 2, 2014

Rare Mouth Ulcer Might Indicate Crohn’s Disease

Crohn's Disease, News

In a recent study entitled “Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report,” the authors highlight the need to recognize Cheilitis granulomatosa lesions in the mouth ... Read more

November 25, 2014November 25, 2014

Heart Attack, Stroke, Diabetes Could Be Avoided Through a Healthy Gut Microbiome

News

A new study entitled “Intestinal Epithelial Cell Toll-like Receptor 5 Regulates the Intestinal Microbiota to Prevent Low-Grade Inflammation and Metabolic Syndrome in Mice,” suggests that maintaining a healthy gut microbiome, ... Read more

November 24, 2014December 1, 2014

Experimental Pediatric Ulcerative Colitis Drug Picks Up Orphan Drug Status

News, Ulcerative colitis

AvaxiaBiologics,Inc. recently announced that the US Food and Drug Administration (FDA) granted their lead experimental drug AVX-470 Orphan Drug Designation for the treatment of pediatric ulcerative colitis. The news comes after the company previously announced the results ... Read more

November 21, 2014November 21, 2014

New Software Solution Pinpoints Gut Metabolites Involved in Gastrointestinal Disease

News

A new study entitled “Prediction and quantification of bioactive microbiota metabolites in the mouse gut” describes a new algorithm capable of predicting and identifying metabolic products produced by microorganisms in ... Read more